Cargando…

Metabolomics Biomarkers: A Strategy Toward Therapeutics Improvement in ALS

Biomarkers research in amyotrophic lateral sclerosis (ALS) holds the promise of improving ALS diagnosis, follow-up of patients, and clinical trials outcomes. Metabolomics have a big impact on biomarkers identification. In this mini-review, we provide the main findings of metabolomics studies in ALS...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lanznaster, Débora, de Assis, Denis Reis, Corcia, Philippe, Pradat, Pierre-François, Blasco, Hélène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neurology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6305341/ https://www.ncbi.nlm.nih.gov/pubmed/30619076 http://dx.doi.org/10.3389/fneur.2018.01126

Ejemplares similares

Is There a Role for Vitamin D in Amyotrophic Lateral Sclerosis? A Systematic Review and Meta-Analysis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Metabolomics as a Crucial Tool to Develop New Therapeutic Strategies for Neurodegenerative Diseases
por: Lanznaster, Débora, et al.
Publicado: (2022)

Metabolomics: A Tool to Understand the Impact of Genetic Mutations in Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Conditioned Medium from Cells Overexpressing TDP-43 Alters the Metabolome of Recipient Cells
por: Hergesheimer, Rudolf, et al.
Publicado: (2020)

A pharmaco-metabolomics approach in a clinical trial of ALS: Identification of predictive markers of progression
por: Blasco, Hélène, et al.
Publicado: (2018)

The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight?
por: Hergesheimer, Rudolf C, et al.
Publicado: (2019)

Frontotemporal Pathology in Motor Neuron Disease Phenotypes: Insights From Neuroimaging
por: McKenna, Mary Clare, et al.
Publicado: (2021)

Editorial: Biomarkers and Clinical Indicators in Motor Neuron Disease
por: Bede, Peter, et al.
Publicado: (2019)

Taking Advantages of Blood–Brain or Spinal Cord Barrier Alterations or Restoring Them to Optimize Therapy in ALS?
por: Alarcan, Hugo, et al.
Publicado: (2022)

Aβ1-42 and Tau as Potential Biomarkers for Diagnosis and Prognosis of Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2020)

Biomarkers of Spinal and Bulbar Muscle Atrophy (SBMA): A Comprehensive Review
por: Querin, Giorgia, et al.
Publicado: (2018)

TDP-43-Mediated Toxicity in HEK293T Cells: A Fast and Reproducible Protocol To Be Employed in the Search of New Therapeutic Options against Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2019)

(1)H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
por: Blasco, Hélène, et al.
Publicado: (2010)

Correction: (1)H-NMR-Based Metabolomic Profiling of CSF in Early Amyotrophic Lateral Sclerosis
por: Blasco, Hélène, et al.
Publicado: (2010)

Status of ALS Treatment, Insights into Therapeutic Challenges and Dilemmas
por: Khamaysa, Mohammed, et al.
Publicado: (2022)

The Roles of NEDD4 Subfamily of HECT E3 Ubiquitin Ligases in Neurodevelopment and Neurodegeneration
por: Haouari, Shanez, et al.
Publicado: (2022)

Spinal Cord Imaging in Amyotrophic Lateral Sclerosis: Historical Concepts—Novel Techniques
por: El Mendili, Mohamed Mounir, et al.
Publicado: (2019)

Tauroursodeoxycholic acid in patients with amyotrophic lateral sclerosis: The TUDCA-ALS trial protocol
por: Albanese, Alberto, et al.
Publicado: (2022)

Study of Ubiquitin Pathway Genes in a French Population with Amyotrophic Lateral Sclerosis: Focus on HECW1 Encoding the E3 Ligase NEDL1
por: Haouari, Shanez, et al.
Publicado: (2023)

Electrophysiological and spinal imaging evidences for sensory dysfunction in amyotrophic lateral sclerosis
por: Iglesias, Caroline, et al.
Publicado: (2015)

An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

Chronic Inflammatory or Chronic Inflammatory Demyelinating Polyradiculoneuropathy?
por: Vallat, Jean-Michel, et al.
Publicado: (2022)

Corrigendum: An Overview of MicroRNAs as Biomarkers of ALS
por: Joilin, Greig, et al.
Publicado: (2019)

Biomarkers for C9orf7-ALS in Symptomatic and Pre-symptomatic Patients: State-of-the-art in the New Era of Clinical Trials
por: Querin, Giorgia, et al.
Publicado: (2022)

Therapeutic strategies for intracerebral hemorrhage
por: Li, Zhe, et al.
Publicado: (2022)

The Relevancy of Data Regarding the Metabolism of Iron to Our Understanding of Deregulated Mechanisms in ALS; Hypotheses and Pitfalls
por: Petillon, Camille, et al.
Publicado: (2019)

Biomarker Supervised G-CSF (Filgrastim) Response in ALS Patients
por: Johannesen, Siw, et al.
Publicado: (2018)

The Italian Version of the ALS Depression Inventory-12
por: Pain, Debora, et al.
Publicado: (2021)

CSF p-tau as a potential cognition impairment biomarker in ALS
por: Gong, Zhongying, et al.
Publicado: (2022)

A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
por: Devos, David, et al.
Publicado: (2019)

Discovery of a New Biomarker Pattern for Differential Diagnosis of Acute Ischemic Stroke Using Targeted Metabolomics
por: Sun, Ruitan, et al.
Publicado: (2019)

Author Correction: A ferroptosis–based panel of prognostic biomarkers for Amyotrophic Lateral Sclerosis
por: Devos, David, et al.
Publicado: (2020)

Biological Significance of microRNA Biomarkers in ALS—Innocent Bystanders or Disease Culprits?
por: Foggin, Sophie, et al.
Publicado: (2019)

A Systematic Review of Suggested Molecular Strata, Biomarkers and Their Tissue Sources in ALS
por: Vijayakumar, Udaya Geetha, et al.
Publicado: (2019)

Metabolic Profile and Pathological Alterations in the Muscle of Patients with Early-Stage Amyotrophic Lateral Sclerosis
por: Lanznaster, Débora, et al.
Publicado: (2022)

Lawsuit and Traumatic Brain Injury: The Relationship Between Long-Lasting Sequelae and Financial Compensation in Litigants. Results From the PariS-TBI Study
por: Bayen, Eléonore, et al.
Publicado: (2019)

Editorial: Effects of epilepsy on memory—Therapeutic implications, biomarkers, and comorbidities
por: Höller, Yvonne, et al.
Publicado: (2023)

Knowledge and Perception Toward Neuromodulation Devices Among Medical Students at Umm Al-Qura University
por: Alqahtani, Taif F, et al.
Publicado: (2023)

New Trends and Most Promising Therapeutic Strategies for Epilepsy Treatment
por: Riva, Antonella, et al.
Publicado: (2021)

Level of Awareness and Attitude Toward Cerebral Palsy Among Parents in Al-Baha City, Saudi Arabia
por: Salih, Elfatih M, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_of5tnf7ch8aggort25jasj7n9m